Misonix announces results of new large real-world studies that further prove efficacy of TheraSkin
Diabetic ulcers were 59% more likely to close in the treatment cohort, compared to the control cohort
06 Dec 19
Diabetic ulcers were 59% more likely to close in the treatment cohort, compared to the control cohort
04 Dec 19
The clinical trial will demonstrate the safety and effectiveness of Renuvion technology for use in dermal resurfacing procedures
03 Dec 19
GE Healthcare’s investment in CMR Surgical, further demonstrates its commitment to improve outcomes for healthcare providers and therapy…
28 Nov 19
Venus Epileve represents a new product introduction that expands the Company’s diode laser hair removal offering beyond the…
15 Nov 19
Launches joint development program for NDIR laser-based diagnostic products to measure glucose, electrolytes and other important biochemical substances…
15 Nov 19
Elekta Unity offers radiation therapy that can be more effective, and means not only fewer treatment-related side effects…
08 Nov 19
SANUWAVE Health is a shockwave technology company initially focused on the development and commercialization of patented noninvasive, biological…
06 Nov 19
Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed
28 Oct 19
Interim results presented at American Society for Dermatologic Surgery annual meeting
28 Oct 19
Sebacia Microparticles is used with 1064nm lasers in photothermal heating of sebaceous glands to treat inflammatory acne vulgaris